Status:
COMPLETED
Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort.
Lead Sponsor:
ANRS, Emerging Infectious Diseases
Conditions:
SARS-CoV Infection
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
This is a prospective, multicentric, non comparative study aiming to evaluate the clinical and virological evolution of high-risk patients infected with SARS-CoV-2 treated withtin the framework of a c...
Eligibility Criteria
Inclusion
- Adults with the criteria for COVID-19 treatment within the French compassionate program (ATU/AAP)
- Adults covered by the French social health coverage
- Adults who signed the informed consent form
Exclusion
- Exclusion criteria described in the French compassionate program (ATU/AAP)
- Patient participating in another biomedical research with an exclusion period ongoing at inclusion
- Vulnerable patient (adults legally protected: under judicial protection, guardianship, or supervision, persons deprived of their liberty)
- Pregnant or breastfeeding woman
Key Trial Info
Start Date :
September 21 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 18 2023
Estimated Enrollment :
756 Patients enrolled
Trial Details
Trial ID
NCT04885452
Start Date
September 21 2021
End Date
December 18 2023
Last Update
May 28 2025
Active Locations (37)
Enter a location and click search to find clinical trials sorted by distance.
1
CH Agen-Nerac
Agen, France
2
CHU d'Angers
Angers, France
3
CHR Metz-Thionville
Ars-Laquenexy, France
4
Hôpital Avicenne
Bobigny, France